Bruno Verhasselt
Overview
Explore the profile of Bruno Verhasselt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1830
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
De Schuyter K, Boelens J, Messiaen A, Schelstraete P, Verhasselt B, Huis Int Veld D, et al.
Eur J Clin Microbiol Infect Dis
. 2023 Nov;
43(1):195-201.
PMID: 37981632
The aim of this study was to assess the reliability of rapid antigen detection tests (RADT) for Streptococcus pyogenes (GAS) and Streptococcus pneumoniae on pleural fluid samples for diagnosis of...
12.
Rudin C, Bollen N, Hong S, Wegner F, Politi L, Mellou K, et al.
Euro Surveill
. 2023 Nov;
28(45).
PMID: 37943503
BackgroundThe earliest recognised infections by the SARS-CoV-2 Omicron variant (Pango lineage B.1.1.529) in Belgium and Switzerland suggested a connection to an international water polo tournament, held 12-14 November 2021 in...
13.
Hamerlinck H, Aerssens A, Boelens J, Dehaene A, McMahon M, Messiaen A, et al.
Antimicrob Resist Infect Control
. 2023 Jun;
12(1):58.
PMID: 37337245
Background: Accumulating evidence shows a role of the hospital wastewater system in the spread of multidrug-resistant organisms, such as carbapenemase producing Enterobacterales (CPE). Several sequential outbreaks of CPE on the...
14.
Strubbe G, Messiaen A, Vandendriessche S, Verhasselt B, Boelens J
Acta Clin Belg
. 2023 Mar;
78(5):385-391.
PMID: 36999562
Objectives: EUCAST breakpoints for short incubation disk diffusion allow rapid antimicrobial susceptibility testing (RAST) directly from positive blood cultures. We evaluate the RAST methodology and assess its potential added value...
15.
Cuypers L, Dellicour S, Hong S, Potter B, Verhasselt B, Vereecke N, et al.
Viruses
. 2022 Oct;
14(10).
PMID: 36298856
An adequate SARS-CoV-2 genomic surveillance strategy has proven to be essential for countries to obtain a thorough understanding of the variants and lineages being imported and successfully established within their...
16.
Crevecoeur J, Hens N, Neyens T, Lariviere Y, Verhasselt B, Masson H, et al.
Vaccine
. 2022 Sep;
40(43):6218-6224.
PMID: 36127210
Introduction: Long term care facilities for elderly (LTCFs) in Europe encountered a high disease burden at the start of the COVID-19 pandemic. Therefore, these facilities were the first to receive...
17.
Cuypers L, Bode J, Beuselinck K, Laenen L, Dewaele K, Janssen R, et al.
Viruses
. 2022 Jun;
14(6).
PMID: 35746765
From early 2020, a high demand for SARS-CoV-2 tests was driven by several testing indications, including asymptomatic cases, resulting in the massive roll-out of PCR assays to combat the pandemic....
18.
Oyaert M, De Scheerder M, Van Herrewege S, Laureys G, Van Assche S, Cambron M, et al.
Front Immunol
. 2022 Apr;
13:858399.
PMID: 35401575
Background: Immunocompromised patients are at increased risk of severe COVID-19 and impaired vaccine response. In this observational prospective study, we evaluated immunogenicity of the BNT162b2 mRNA vaccine in cohorts of...
19.
Heireman L, Vandendriessche S, Coorevits L, Buyle F, De Waele J, Vogelaers D, et al.
Eur J Hosp Pharm
. 2022 Feb;
29(2):79-83.
PMID: 35190452
Objective: To reduce the inappropriate use of broad-spectrum antibiotics in a 1000+ bed acute tertiary care hospital by the introduction of cascade antimicrobial susceptibility reporting for Enterobacterales. Methods: Over a...
20.
Vanderheijden N, Stevaert A, Xie J, Ren X, Barbezange C, Noppen S, et al.
Front Immunol
. 2022 Jan;
12:790415.
PMID: 35069571
To face the continuous emergence of SARS-CoV-2 variants, broadly protective therapeutic antibodies are highly needed. We here focused on the fusion peptide (FP) region of the viral spike antigen since...